CEO Murali Prahalad says Epic Sciences Inc. will use a fresh round of funding to bring a test for prostate cancer to market.

CEO Murali Prahalad says Epic Sciences Inc. will use a fresh round of funding to bring a test for prostate cancer to market. Photo by Jamie Scott Lytle.

photo

Aaron Oh works on cell deposition in the company’s lab.

— Armed with $40 million in fresh capital, Epic Sciences Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129